Fig. 2From: Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccineRisk of any adverse events following immunization in RMD patients and controls according to age and sex. AEFI, adverse events following immunization; HC, healthy controls; RMD, rheumatic musculoskeletal diseaseBack to article page